Ocular surface investigations in dry eye;Méthodes d'évaluation de la surface oculaire dans les syndromes secs

Journal Francais d'Ophtalmologie

Volumn 30, Issue 1, 2007, Pages 76-97

  Labbe A ^a,b   Brignole Baudouin, F ^b,c   Baudouin, C ^a,b  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b INSERM   (France)

^c Centre Universitaire des Saints Pères   (France)

Author keywords

Dry eye; Ocular surface; Sj gren's syndrome; Tear film; Tests

Indexed keywords

ANTINUCLEAR ANTIBODY; LACTOFERRIN; LYSOZYME; TEAR PROTEIN;

BIOMICROSCOPY; BIOPSY; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CORNEA DISEASE; CYTOPATHOLOGY; DRY EYE; ELECTROPHORESIS; EVAPORATION; FLOW CYTOMETRY; FLUOROPHOTOMETRY; HISTOPATHOLOGY; HUMAN; OPHTHALMOLOGY; OSMOLARITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SJOEGREN SYNDROME; TEAR FILM; THERMOGRAPHY;

EID: 33846643621     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(07)89557-x     Document Type: Review

References (128)

1. Creuzot-Garcher C. The tear film. In: Hoang Xuan T, ed. Inflammatory Diseases of the Conjunctiva. Stuttgart, Germany: Thieme Medical Publishers; 2001:8-10.
2. Prydal JI, Campbell FW. Study of precorneal tear film thickness and structure by interferometry and confocal microscopy. Invest Ophthalmol Vis Sci, 1992;33:1996-2005.
3. Prydal JI, Artal P, Woon H, Campbell FW. Study of human precorneal tear film thickness and structure using laser interferometry and confocal microscopy. Invest Ophthalmol Vis Sci, 1992;33:2006-11.
4. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res, 2004;78:347-60.
5. Glasgow BJ, Marshall G, Gasymov OK, Abduragimov AR, Yusifov TN, Knobler CM. Tear lipocalins: potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci, 1999;40:3100-7.
6. Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res, 2004;78:379-388.
7. Carraway KL, Ramsauer VP, Haq B, Carothers Carraway CA[RCP24]. Cell signaling through membrane mucins. Bioessays, 2003;25:66-71.
8. Liu B, Rament SA, Gyurko C, Oppenheim FG, Offner GD, Troxler RF. The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity. Biochem J, 2000;345:557-64.
9. Tiffany JM, Nagyova B. The role of lipocalin in determining the physical properties of tears. Adv Exp Med Biol, 2002;506:581-5.
10. Nagyova B, Tiffany JM. Components responsible for the surface tension of human tears. Curr Eye Res, 1999;19:4-11.
11. Chew CK, Hykin PG, Jansweijer C, Dikstein S, Tiffany JM, Bron AJ. The casual level of meibomian lipids in humans. Curr Eye Res, 1993;12:255-9.
12. Chew CK, Jansweijer C, Tiffany JM, Dikstein S, Bron AJ. An instrument for quantifying meibomian lipid on the lid margin: the Meibometer. Curr Eye Res, 1993;12:247-54.
13. Tsai PS, Evans JE, Green KM, Sullivan RM, Schaumberg DA, Richards SM, Dana MR, Sullivan DA. Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol, 2006;90:372-7.
14. Shine WE, Silvany R, Mcculley JP. Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Invest Ophthalmol Vis Sci, 1993;34:2291-6.
15. Tiffany JM. The role of meibomian secretion in the tears. Trans Ophthalmol Soc UK, 1985;104:396-401.
16. Saaren-Seppala H, Jaunhiainen M, Tervo T, Redl B, Kinnunen PK, Holopainen JM. Interaction of purified tear lipocalin with lipid membranes. Invest Ophthalmol Vis Sci, 2005;46:3649-56.
17. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea, 2004;23:272-85.
18. Mainstone JC, Bruce AS, Golding TR. Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res, 1996;15:653-61.
19. Bron AJ. The Doyne lecture. Reflections on the tears. Eye, 1997;11:583-602.
20. Yokoi N, Komuro A. Non-invasive methods of assessing the tear film. Exp Eye Res, 2004;78:399-407.
21. Wang J, Aquavella J, Palakuru J, Chung S. Repeated measurements of dynamic tear distribution on the ocular surface after instillation of artificial tears. Invest Ophthalmol Vis Sci, 2006;47:3325-9.
22. Gray JR, Mosier MA, Ishimoto BM. Optimized protocol for Flourotron Master. Graefes Arch Clin Exp Ophthalmol, 1985;222:225-9.
23. Sorbara L, Simpson T, Vaccari S, Jones L, Fonn D. Tear turnover rate is reduced in patients with symptomatic dry eye. Cont Lens Anterior Eye, 2004;27:15-20.
24. Eter N, Gobbels M. A new technique for tear film fluorophotometry. Br J Ophthalmol, 2002;86:616-9.
25. Tomlinson A, Khanal S. Assessment of tear film dynamics: quantification approach. The Ocular Surface, 2005;3:81-95.
26. Nichols JJ, Berntsen DA, Mitchell GL, Nichols KK. An assessment of grading scales for meibography images. Cornea, 2005;24:382-8.
27. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology, 1998;105:1485-8.
28. Yokoi N, Mossa F, Tiffany JM, Bron AJ. Assessment of meibomian gland function in dry eye using meibometry. Arch Ophthalmol, 1999;117:723-9.
29. Komuro A, Yokoi N, Kinoshita S, Tiffany JM, Bron AJ, Suzuki T. Assessment of meibomian gland function by a newly-developed laser meibometer. Adv Exp Med Biol, 2002;506:517-20.
30. Guillon M, Styles E, Guillon JP, Maissa C. Preocular tear film characteristics of nonwearers and soft contact lens wearers. Optom Vis Sci, 1997;74:273-9.
31. Doane MG. An instrument for in vivo tera film interferometry. Optom Vis Sci, 1989;66:383-8.
32. Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Invest Ophthalmol Vis Sci, 2006;47:1319-28.
33. Ounnoughene Y, Benhatchi N, Agboke J, Beauchet A, Baudouin C. Le Vidéo tearscope: une nouvelle méthode d'évaluation du film lacrymal in vivo. J Fr Ophtalmol, 2006;29:476-84.
34. Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol, 1996;122:818-24.
35. Isenberg SJ, Del Signore M, Chen A, Wei J, Guillon JP. The lipid layer and stability of the preocular tear film in newborns and infants. Ophthalmology, 2003;110:1408-11.
36. Goto E, Tseng SC. Kinetic analysis of tear interference images in aqueous tear deficiency dry eye before and after punctal occlusion. Invest Ophthalmol Vis Sci, 2003;44:1897-905.
37. Goto E, Tseng SC. Differentiation of lipid tear deficiency dry eye by kinetic analysis of tear interference images. Arch Ophthalmol, 2003;121:173-80.
38. Goto E, Dogru M, Kojima T, Tsubota K. Computer-synthesis of an interference color chart of human tear lipid layer, by a colorimetric approach. Invest Ophthalmol Vis Sci, 2003;44:4693-7.
39. Mathers W. Evaporation from the ocular surface. Exp Eye Res, 2004;78:389-94.
40. Rolando M, Refojo MF. Tear evaporimeter for measuring water evaporation rate from the tear film under controlled conditions in humans. Exp Eye Res, 1983;36:25-33.
41. Tsubota K, Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci, 1992;33:2942-50.
42. Rolando M, Refojo MF, Kenyon KR. Increased tear evaporation in eyes with keratoconjunctivitis sicca. Arch Ophthalmol, 1983;101:557-8.
43. Craig JP, Singh I, Tomlinson A, Morgan PB, Efron N. The role of tear physiology in ocular surface temperature. Eye, 2000;14:635-41.
44. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology, 1993;100:347-51.
45. Mori A, Oguchi Y, Okusawa Y, Ono M, Fujishima H, Tsubota K. Use of high-speed, high-resolution thermography to evaluate the tear film layer. Am J Ophthalmol, 1997;124:729-35.
46. Morgan PB, Tullo AB, Efron N. Infrared thermography of the tear film in dry eye. Eye, 1995;9:615-8.
47. Tutt R, Bradley A, Begley C, Thibos LN. Optical and visual impact oftear break-up in human eyes. Invest Ophthalmol Vis Sci, 2000;41:4117-23.
48. Goto T, Zheng X, Klyce SD, Kataoka H, Uno T, Karon M, et al. A new method for tear film stability analysis using videokeratography. Am J Ophthalmol, 2003;135:607-12.
49. Dogru M, Tsubota K. New insights into the diagnosis and treatment of dry eye. Ocular Surface, 2004;2:59-75.
50. Nemeth J, Erdelyi B, Csakany B, Gaspar P, Soumelidis A, Kahlesz F, et al. High-speed videotopographic measurement of tear film build-up time. Invest Ophthalmol Vis Sci, 2002;43:1783-90.
51. Koh S, Maeda N, Kuroda T, Hori Y, Watanabe H, Fujikado T, et al. Effect of tear film break-up on higher-order aberrations measured with wavefront sensor. Am J Ophthalmol, 2002;134:115-7.
52. Lin YY, Carrel H, Wang IJ, Lin PJ, Hu FR. Effect of tear film break-up on higher order aberrations of the anterior cornea in normal, dry, and post-LASIK eyes. J Refract Surg, 2005;21:S525-9.
53. Montes-Mico R, Caliz A, Alio JL. Wavefront analysis of higher order aberrations in dry eye patients. J Refract Surg, 2004;20:243-7.
54. De Nicola R, Labbé A, Amar N, Dupas B, Baudouin C. Microscopie confocale et pathologies de la surface oculaire : corrélations anatomo-cliniques. J Fr Ophtalmol, 2005;28:691-8.
55. Thatcher RW, Darougar S, Jones BR. Conjunctival impression cytology. Arch Ophthalmol, 1977;95:678-81.
56. Egbert PR, Lauber S, Maurice D. A simple conjunctiva biopsy. Am J Ophthalmol, 1977;84:798-801.
57. Brignole F, Becquet F, Pisella PJ, Goguel A, Baudouin C. Expression of Fas antigen (CD95) in the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory conditions. Exp Eye Res, 1998;67:687-97.
58. Baudouin C. The pathology of dry eye. Surv Ophthalmol, 2001; 45(suppl 2):S211-20.
59. Brignole-Baudouin F, Ott AC, Warnet JM, Baudouin C. Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies. Exp Eye Res, 2004;78:473-81.
60. Nelson JD. Impression cytology. Cornea, 1988;7:71-81.
61. Puangsricharern V, Tseng SC. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology, 1995;102:1476-85.
62. Florakis GJ, Folberg R, Krachmer JH, Tse DT, Roussel TJ, Vrabec MP. Elevated corneal epithelial lines in Acanthamoeba keratitis. ArchOphthalmol, 1988;106:1202-6.
63. Thiel MA, Bossart W, Bernauer W. Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections. Br J Ophthalmol, 1997;81:984-8.
64. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol, 2006;17:327-31.
65. Calonge M, Diebold Y, Saez V, Enriquez de Salamanca A, Garcia-Vazquez C, Corrales RM, et al. Impression cytology of the ocular surface: a review. Exp Eye Res, 2004;78:457-72.
66. Nelson JD, Wright JD. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol, 1984;102:1049-51.
67. Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology, 1985;92:728-33.
68. Adams GG, Dilly PN, Kirkness CM. Monitoring ocular disease by impression cytology. Eye, 1988;2:506-16.
69. Bjerrum KB. Snake-like chromatin in conjunctival cells of normal elderly persons and of patients with primary Sjögren's syndrome and other connective tissue diseases. Acta Ophthalmol Scand, 1995;73:33-6.
70. Rolando M, Terragna F, Giordiano G, Calabria G. Conjunctival surface damage distribution in keratoconjunctivitis sicca: an impresion cytology study. Ophthalmologica, 1990;200:170-6.
71. Connor CG, Campbell JB, Steel SA, Burke JH. The effects of daily wear contact lenses on goblet cell density. J Am Optom Assoc, 1994;65:792-4.
72. Chen JJY, Tseng SCG. Abnormal corneal epithelial wound healing in partial-thickness removal of limbal epithelium. Invest Ophthalmol Vis Sci, 1991;32:2219-33.
73. Pisella PJ, Brignole F, Debbasch C, Lozato PA, Creuzot-Garcher C, Bara J, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmology, 2000;107:1841-9.
74. Marner K. Snake-like appearance of nuclear chromatin in conjunctival epithelial cells from patients with keratoconjunctivitis sicca. Acta Ophthalmol (Copenh), 1980;58:849-53.
75. Baudouin C, Haouat N, Brignole-Baudouin F, Bayle J, Gastaud P. Immunopathological findings in conjunctival cells using immunofluorescence staining of impression cytology specimens. Br J Ophthalmol, 1992;76:545-9.
76. Leonardi A, Busato F, Fregona I, Plebani M, Secchi AG. Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model. Br J Ophthalmol, 2000;84:1228-32.
77. Fujihara T, Takeuchi T, Saito K, Kitajima Y, Kobayashi TK, Tsubota K. Evaluation of human conjunctival epithelium by a combination of brush cytology and flow cytometry: an approach to the quantitative technique. Diagn Cytopathol, 1997;17:456-60.
78. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci, 1997;38:1458-64.
79. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers inconjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci, 2000;41:1356-63.
80. Baudouin C, Bourcier T, Brignole F, Bertel F, Moldovan M, Goldschild M, et al. Correlation between tear IgE levels and HLA DR expression by conjunctival cells in allergic and nonallergic chronic conjunctivitis. Graefes Arch Clin Exp Ophthalmol, 2000;238:900-4.
81. Pisella PJ, Debbasch C, Hamard P, Creuzot-Garcher C, Rat P, Brignole F, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost, preserved timolol and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci, 2004;45:1360-8.
82. Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Bensoussan L, Brignole F. Conjunctival epithelial cells from longterm treated glaucoma patients exhibit inflammatory cytokines. Ophthalmology, 2004;111:2186-92.
83. Baudouin C, Liang H, Bremond-Gignac D, Hamard P, Hreiche R, Creuzot-Garcher C, et al. CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of TH1/TH2 in ocular surface disorders. J Allergy Clin Immunol, 2005;116:614-9.
84. Gulati A, Saccheti M, Bonini S, Dana R. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol, 2006;124:710-6.
85. Mietz H, Niesen U, Krieglstein GK. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol, 1994;232:561-5.
86. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea, 1998;17:584-9.
87. Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci, 2001;42:90-5.
88. Herreras JM, Pastor JC, Colonge M, Asensio VM. Ocular surface alteration after long-term treatment with an antiglaucomatous drug. Ophthalmology, 1992;99:1082-8.
89. Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint Jean M, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology, 1999;106:556-63.
90. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjogren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci, 1994;35:3493-504.
91. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res, 1999;19:201-11.
92. Henderson TRM, Coster DJ, Williams KA. The long term outcome of limbal allografts: the search for surviving cells. Br J Ophthalmol, 2001;85:604-9.
93. Corrales RM, Galarreta DJ, Herreras JM, Calonge M, Chaves FJ. Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes. Arch Soc Esp Oftalmol, 2003;78:375-82.
94. Fukuda M, Wang HF. Dry eye and closed eye tears. Cornea, 2000;19(suppl 1):S44-8.
95. Glasson MJ, Stapleton F, Keay L, Sweeney D, Willcox MD. Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers. Invest Ophthalmol Vis Sci, 2003;44:5116-24.
96. Ng V, Cho P, Mak S, Lee A. Variability of tear protein levels in normal young adults: between-day variation. Graefes Arch Clin Exp Ophthalmol, 2000;238:892-9.
97. Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocular Surface. 2004;2:124-30.
98. Gilbard JP, Farris RL, Santamaria J. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol, 1978;96:677-81.
99. Sullivan B, Angeles R, Lemp MA et al. Presented at the 4th International Conference on the Lacrimal Gland, Tear Film, Ocular Surface and Dry Eye Syndromes. Puerto Rico, November 20, 2004.
100. Batellier L, Rea A, Chaumeil C, Scat Y. Protein evaluation of tears: different biological parameters and their respective value. J Fr Ophtalmol, 1996;19:520-6.
101. Reitz C, Breipohl W, Augustin A, Bours J. Analysis of tear proteins by one- and two-dimensional thin-layer isoelectric focusing, sodium dodecyl sulfate electrophoresis and lectin blotting. Detection of a new component: cystatin C. Graefes Arch Clin Exp Ophthalmol, 1998;236:894-9.
102. Kuizenga A, van Haeringen NJ, Kijlstra A. SDS-Minigel electrophoresis of human tears. Effect of sample treatment on protein patterns. Invest Ophthalmol Vis Sci, 1991;32:381-6.
103. Sitaramamma T, Shivaji S, Rao GN. HPLC analysis of closed, open, and reflex eye tear proteins. Indian J Ophthalmol, 1998;46:239-45.
104. Bjerrum KB. The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjogren's syndrome. Acta Ophthalmol Scand, 1997;75:507-11.
105. Van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol, 1981;26:84-96.
106. Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol, 2003;136:291-9.
107. Klaeger AJ, Whitcher JP, Daniels TE. Tear lysozyme activity in frozen Schirmer strips and salivary gland biopsy as parameters of lacrimal gland function. Ocul Immunol Inflamm, 1999;7:3-6.
108. Sen DK, Sarin GS. Immunoassay of human tear lysozyme. Am J Ophthalmol, 1980;90:715-8.
109. Da Dalt S, Moncada A, Priori R, Valesini G, Pivetti-Pezzi P. The lactoferrin tear test in the diagnosis of Sjogren's syndrome. Eur J Ophthalmol, 1996;6:284-6.
110. Yolton DP, Mende S, Harper A, Softing A. Association of dry eye signs and symptoms with tear lactoferrin concentration. J Am Optom Assoc, 1991;62:217-32.
111. Glasson M, Stapleton F, Willcox M. Lipid, lipase and lipocalin differences between tolerant and intolerant contact lens wearers. Curr Eye Res, 2002;25:227-35.
112. Rolando M. Tear mucus ferning test in normal and keratoconjunctivitis sicca eyes. Chibret Int J Ophthalmol, 1984;2:32-9.
113. Boukes RJ, Boonstra A, Breebaart AC, Reits D, Glasius E, Luyendyk L, et al. Analysis of human tear protein profiles using high performance liquid chromatography (HPLC). Doc Ophthalmol, 1987;67:105-13.
114. Schmut O, Horwath-Winter J, Zenker A, Trummer G. The effect of sample treatment on separation profiles of tear fluid proteins: qualitative and semi-quantitative protein determination by an automated analysis system. Graefes Arch Clin Exp Ophthalmol, 2002;240:900-5.
115. Varnell RJ, Freeman JY, Maitchouk D, Beuerman RW, Gebhardt BM. Detection of substance P in human tears by laser desorption mass spectrometry and immunoassay. Graefes Arch Clin Exp Ophthalmol, 1995;233:694-8.
116. de Souza GA, Godoy LM, Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and proteases inhibitors. Genome Biol, 2006;7:R72.
117. Smith VA, Rishmawi H, Hussein H, Easty DL. Tear film MMP accumulation and corneal disease. Br J Ophthalmol, 2001;85:147-53.
118. Zhao H, Jumblatt JE, Wood TO, Jumblatt MM. Quantification of MUC5AC protein in human tears. Cornea, 2001;20:873-7.
119. Garcher C, Bron A, Baudouin C, Bildstein L, Bara J. CA 19-9 ELISA test: a new method for studying mucus changes in tears. Br J Ophthalmol, 1998;82:88-90.
120. Wollensak G, Mur E, Mayr A, Baier G, Gottinger W, Stoffler G. Effective methods for the investigation of human tear film proteins and lipids. Graefes Arch Clin Exp Ophthalmol, 1990;228:78-82.
121. Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res, 2003;26:89-94.
122. Nakamura Y, Sotozono C, Kinoshita S. Inflammatory cytokines in normal human tears. Curr Eye Res, 1998;17:673-6.
123. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci, 2001;42:2283-92.
124. Virtanen T, Konttinen YT, Honkanen N, Harkonen M, Tervo T. Tear fluid plasmin activity of dry eye patients with Sjögren's syndrome. Acta Ophthalmol Scand, 1997;75:137-41.
125. Augustin AJ, Spitznas M, Kaviani N, Meller D, Koch FH, Grus F, et al. Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Arch Clin Exp Ophthalmol, 1995;233:694-8.
126. Toker E, Yavuz S, Direskeneli H. Anti-Ro/ SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome. Br J Ophthalmol, 2004;88:384-7.
127. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome: specificity and sensitivity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis, 1994;53:637C47.
128. Aguilar AJ, Fonseca L, Croxatto JO. Sjogren's syndrome: a comparative study of impression cytology of the conjunctiva and buccal mucosa and salivary gland biopsy. Cornea, 1991;10:203-6.